Page D L, Dupont W D
Vanderbilt University Medical Center, Department of Pathology, Nashville, Tennessee 37232.
J Cell Biochem Suppl. 1992;16G:175-82. doi: 10.1002/jcb.240501130.
Specific atypical histological patterns of epithelial hyperplasia (AH) indicate a medically relevant risk of breast cancer development in 5-10% of women with otherwise benign biopsies. This risk is about four times that of similar women, i.e., of the same age and at risk for the same length of time. These relative risks are not stable with time and fall 10-15 years after detection. Absolute risk for invasive breast cancer after AH is about 10% in 10-15 years after biopsy and is most certain for perimenopausal women. Proliferative disease without atypia predicts only a slight elevation of risk with a relative risk (RR) of 1.5 to 2 times that of the general population. There is such a strong interaction between family history and AH that it is relevant to consider women with atypical hyperplasia who have a positive family history (FH) of breast cancer separately from those who do not. The absolute risk of breast cancer development in women with AH without a FH was 8% in 10 years (RR about 4), whereas those with a positive family history experienced a risk of about 20% at 15 years (RR of about 10). This interaction of AH and FH has also been observed in other recent studies. Low replacement doses of conjugated estrogen after menopause do not further elevate risk beyond that identified by histology.(ABSTRACT TRUNCATED AT 250 WORDS)
上皮增生(AH)的特定非典型组织学模式表明,在活检结果为良性的女性中,有5%-10%存在与医学相关的乳腺癌发病风险。这种风险约为年龄相仿、处于相同风险时长的类似女性的四倍。这些相对风险并不随时间稳定,在检测后10-15年下降。AH后发生浸润性乳腺癌的绝对风险在活检后10-15年约为10%,在围绝经期女性中最为确定。无异型性的增生性疾病仅预示风险略有升高,相对风险(RR)为普通人群的1.5至2倍。家族史与AH之间存在强烈的相互作用,因此有必要将有乳腺癌家族史(FH)阳性的非典型增生女性与无家族史的女性分开考虑。无家族史的AH女性患乳腺癌的绝对风险在10年内为8%(RR约为4),而家族史阳性的女性在15年时的风险约为20%(RR约为10)。AH与FH之间的这种相互作用在其他近期研究中也有观察到。绝经后低剂量的结合雌激素替代疗法不会使风险进一步升高超过组织学所确定的风险。(摘要截选至250字)